Cleared Traditional

K110186 - SYNAPSE 3D LIVER ANALYSIS

K110186 is an FDA 510(k) clearance for SYNAPSE 3D LIVER ANALYSIS, manufactured by Fujifilm Medical System U.S.A., Inc.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 76-day FDA review.

K110186 · Fujifilm Medical System U.S.A., Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2011
Decision
76d
Days
Class 2
Risk

K110186 is an FDA 510(k) clearance for the SYNAPSE 3D LIVER ANALYSIS. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Fujifilm Medical System U.S.A., Inc. (Stamford, US). The FDA issued a Cleared decision on April 7, 2011 after a review of 76 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Fujifilm Medical System U.S.A., Inc. devices

FDA 510(k) Submission Details - K110186

510(k) Number K110186 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 21, 2011
Decision Date April 07, 2011
Days to Decision 76 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
31d faster than avg
Panel avg: 107d · This submission: 76d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1889
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K110186.
SYMBIA.NET
K110844 · Siemens Medical Solutions USA, Inc. · Apr 2011
MEDVOXEL HEARTPRO SOFTWARE APPLICATION
K103565 · Medvoxel Systems, Inc. · Apr 2011
IMAGE-ARENA AND IMAGE-ARENA APPLICATIONS
K110667 · Tomtec Imaging Systems GmbH · Apr 2011
4D SONO-SCAN 1.0
K110595 · Tomtec Imaging Systems GmbH · Apr 2011
SYNGO MBF
K110494 · Siemens Medical Solutions USA, Inc. · Apr 2011
CLEARCANVAS RIS / PACS
K110332 · Clearcanvas, Inc. · Mar 2011